CEO Kevin Hrusovsky wows a packed audience with Quanterix' vision and progress towards transforming healthcare at the 2019 J.P. Morgan Health Conference in San Francisco.
In The News
FierceBiotech | November 19, 2018
by Conor Hale
PharmaVOICE | November 16, 2018
Contributed by: Denise Myshko
Thrive Global | November 12, 2018
This Sunday was Veterans Day, a time to honor those who have selflessly served our country. While our veterans are front and center on this day, they have been missing from a critical conversation over the past couple of years. By Kevin Hrusovsky
GenomeWeb | November 08, 2018
Nov 07, 2018 | Adam Bonislawski
GenomeWeb | November 07, 2018
NEW YORK (GenomeWeb) – Expedeon said today it has signed a supply and license agreement with Quanterix to provide that company non-exclusive access to its immunoassay offerings.